Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis.

Authors :: Furtado VF
Brauneis D
Weinberg J
Elhassan N
Sloan JM
Sanchorawala V
Source :: Bone marrow transplantation [Bone Marrow Transplant] 2022 Feb; Vol. 57 (2), pp. 306-308. Date of Electronic Publication: 2021 Nov 29.
Publication Year :: 2022

Subjects :: Humans
Immunoglobulin Light Chains
Melphalan therapeutic use
Stem Cell Transplantation
Transplantation Conditioning
Transplantation, Autologous
Treatment Outcome
Hematopoietic Stem Cell Transplantation
Immunoglobulin Light-chain Amyloidosis therapy

Full Text Access

Tools